February 22, 2017 6:28 PM ET


Company Overview of Prevacus, Inc.

Company Overview

Prevacus, Inc., a drug development company, is engaged in the prevention and treatment of mild traumatic brain injury or concussion. It provides Prevasol nasal spray, which is used to reduce edema, inflammation, and oxidative stress. The company was founded in 2012 and is based in Tallahassee, Florida.

2035 East Paul Dirac Drive

Suite 106

Innovation Park

Tallahassee, FL 32310

United States

Founded in 2012



Key Executives for Prevacus, Inc.

Founder and Lead Scientific Consultant
Chief Scientific Officer
Compensation as of Fiscal Year 2016.

Prevacus, Inc. Key Developments

Prevacus, Inc. to Begin Phase 1 Clinical Studies of PRV-002 for the Treatment of Concussion

Prevacus, Inc. announced plans to initiate Phase 1 clinical studies of a novel treatment for concussion in humans. The company expects to initiate its Phase 1 trial during the first half of 2017. These clinical studies will examine the potential of Prevacus' proprietary compound PRV-002 for concussion treatment in humans. In pre-clinical animal studies, the compound performed positively in all measured areas, including memory score, sensory-motor function, anxiety, cerebral edema, cell death and cellular regeneration. PRV-002 is administered nasally providing for a 4-fold higher exposure to the injured brain while simultaneously reducing potential adverse effects on other regions of the body. Furthermore, the compound appears to be over 380-fold safe in toxicology and safety studies in three separate species.

Prevacus, Inc. Presents at 2015 BioFlorida Annual Conference, Oct-12-2015 09:55 AM

Prevacus, Inc. Presents at 2015 BioFlorida Annual Conference, Oct-12-2015 09:55 AM. Venue: Omni Orlando Resort at ChampionsGate, 1500 Masters Blvd, ChampionsGate, FL 33896, United States. Speakers: Jacob Vanlandingham, Founder and Lead Scientific Consultant.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Prevacus, Inc., please visit www.prevacus.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.